• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine

Patent holdings for IPC class A61K 31/4375

Total number of patents in this class: 3986

10-year publication summary

223
298
267
270
296
306
324
380
344
226
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Deciphera Pharmaceuticals, LLC
267
73
Novartis AG
10173
58
Incyte Corporation
1066
49
F. Hoffmann-La Roche AG
7808
47
Immunomedics, Inc.
239
44
Merck Sharp & Dohme LLC
3737
44
Bristol-myers Squibb Company
4757
43
Merck Patent GmbH
5735
38
Hoffmann-La Roche Inc.
3818
37
Bayer Pharma AG
1009
35
Boehringer Ingelheim International GmbH
4486
34
Gilead Sciences, Inc.
2236
33
Shenzhen HighTide Biopharmaceutical, Ltd.
69
32
Bayer AG
3522
31
Pfizer Inc.
3409
27
Takeda Pharmaceutical Company Limited
2700
27
Pliant Therapeutics, Inc.
66
25
Nanjing Nutrabuilding Bio-Tech Co., Ltd.
273
24
Neurocrine Biosciences, Inc.
463
24
Genentech, Inc.
4114
23
Other owners 3238